A prescription drug debate is raging on Beacon Hill. A bill would force pharmaceutical companies to make public their costs, and possibly even cap prices, the first time anywhere in the U.S. Executive Director of Health Care For All, Amy Whitcomb Slemmer, and Executive Chair of XyloCor Therapeutics,Glenn Batchelder, discuss.